Preferred Pharmaceuticals Losartan Potassium Tab Recall

Why it was recalled

CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits.

Product description

Losartan Potassium Tab. USP 50mg, Pkg Size: 30, Mfg: Lupin Pharmaceuticals, Inc., Preferred Pharmaceuticals, Inc.

Lot numbers, UPCs & expiration codes

Lot: E1321O, Exp.: 5/31/2023 Lot: E2521H, Exp.: 5/31/2023 Lot: E2621F, Exp.: 5/31/2023

Where it was sold

Nationwide within the U.S to CA, IN and FL.

What to do if you have this product

Compare the lot number and expiration date on your package with the codes above.
Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
If you have symptoms you think are related, contact your doctor. In an emergency call 911.
Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number: D-0789-2022
Classification: Class II
Status: Terminated
Recall initiated: Apr 12, 2022
FDA report date: May 4, 2022
Quantity: 44 Bottles of 90 Tablets 33 Bottles of 30 Tablets
Recall type: Voluntary: Firm initiated
Recalling firm: Preferred Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-0789-2022, exactly as published.

Show all FDA fields

City: Anaheim
State: CA
Status: Terminated
Country: United States
Event ID: 90001
Address: 1250 N Lakeview Ave Ste O
Code information: Lot: E1321O, Exp.: 5/31/2023 Lot: E2521H, Exp.: 5/31/2023 Lot: E2621F, Exp.: 5/31/2023
Postal code: 92807-1801
Report date: May 4, 2022
Product type: Drugs
Recall number: D-0789-2022
Classification: Class II
Recalling firm: Preferred Pharmaceuticals, Inc.
Product quantity: 44 Bottles of 90 Tablets 33 Bottles of 30 Tablets
Termination date: Sep 22, 2022
Reason for recall: CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits.
Voluntary / mandated: Voluntary: Firm initiated
Product description: Losartan Potassium Tab. USP 50mg, Pkg Size: 30, Mfg: Lupin Pharmaceuticals, Inc., Preferred Pharmaceuticals, Inc.
Distribution pattern: Nationwide within the U.S to CA, IN and FL.
Recall initiation date: Apr 12, 2022
Initial firm notification: Letter
Center classification date: Apr 26, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0789-2022, published May 4, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: Oct 2, 2026. Content last changed: Oct 2, 2026.

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.